Baird Downgrades Immucor (BLUD) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts BLUD Hot Sheet
Price: $26.81 --0%
Rating Summary:
1 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 21 | New: 69
Rating Summary:
1 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 21 | New: 69
Join SI Premium – FREE
Baird downgraded Immucor (NASDAQ: BLUD) from Outperform to Neutral. PT raised from $26 to $27.
For more ratings news on Immucor click here and for the rating history of Immucor click here.
Shares of Immucor closed at $26.98 yesterday.
For more ratings news on Immucor click here and for the rating history of Immucor click here.
Shares of Immucor closed at $26.98 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Double Downgrades Adobe (ADBE) to Underweight, 'more cautious on front office + creative'
- Deutsche Bank Downgrades flatexDEGIRO AG (FTKn:GR) (FNNTF) to Hold
- Roth/MKM Downgrades NeuroSense Therapeutics Ltd. (NRSN) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Robert W BairdSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
